Effects of Totum-63 on glucose homeostasis and postprandial glycemia: a translational study

Am J Physiol Endocrinol Metab. 2021 Jun 1;320(6):E1119-E1137. doi: 10.1152/ajpendo.00629.2020. Epub 2021 May 3.

Abstract

Global prevalence of type 2 diabetes (T2D) is rising and may affect 700 million people by 2045. Totum-63 is a polyphenol-rich natural composition developed to reduce the risk of T2D. We first investigated the effects of Totum-63 supplementation in high-fat diet (HFD)-fed mice for up to 16 wk and thereafter assessed its safety and efficacy (2.5 g or 5 g per day) in 14 overweight men [mean age 51.5 yr, body mass index (BMI) 27.6 kg·m-2] for 4 wk. In HFD-fed mice, Totum-63 reduced body weight and fat mass gain, whereas lean mass was unchanged. Moreover, fecal energy excretion was higher in Totum-63-supplemented mice, suggesting a reduction of calorie absorption in the digestive tract. In the gut, metagenomic analyses of fecal microbiota revealed a partial restoration of HFD-induced microbial imbalance, as shown by principal coordinate analysis of microbiota composition. HFD-induced increase in HOMA-IR score was delayed in supplemented mice, and insulin response to an oral glucose tolerance test was significantly reduced, suggesting that Totum-63 may prevent HFD-related impairments in glucose homeostasis. Interestingly, these improvements could be linked to restored insulin signaling in subcutaneous adipose tissue and soleus muscle. In the liver, HFD-induced steatosis was reduced by 40% (as shown by triglyceride content). In the subsequent study in men, Totum-63 (5 g·day-1) improved glucose and insulin responses to a high-carbohydrate breakfast test (84% kcal carbohydrates). It was well tolerated, with no clinically significant adverse events reported. Collectively, these data suggest that Totum-63 could improve glucose homeostasis in both HFD-fed mice and overweight individuals, presumably through a multitargeted action on different metabolic organs.NEW & NOTEWORTHY Totum-63 is a novel polyphenol-rich natural composition developed to reduce the risk of T2D. Totum-63 showed beneficial effects on glucose homeostasis in HFD-fed mice, presumably through a multitargeted action on different metabolic organs. Totum-63 was well tolerated in humans and improved postprandial glucose and insulin responses to a high-carbohydrate breakfast test.

Keywords: diabetes; glucose; prevention; translational.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Animals
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Chrysanthemum / chemistry
  • Cynara scolymus / chemistry
  • Glycemic Control / methods
  • Homeostasis / drug effects
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / metabolism
  • Hyperglycemia / prevention & control*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged
  • Olea / chemistry
  • Overweight / blood
  • Overweight / drug therapy
  • Overweight / metabolism
  • Pilot Projects
  • Piper nigrum / chemistry
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Postprandial Period / drug effects
  • Translational Research, Biomedical
  • Vaccinium myrtillus / chemistry

Substances

  • Blood Glucose
  • Plant Extracts
  • olive leaf extract